Data61, a CSIRO entity is the largest data innovation group in Australia. Offering the research capabilities, IP and collaboration programs, Data61 provides accelerated commercialisation paths for data-centric R&D and drives collaboration across industry, academia, government and the startup space.
Data61 engaged gemaker to perform detailed and specific market research within the pharmaceutical market.
gemaker supplied specific, detailed and accurate market research in a very tight timeframe. Drawing on in-house experience and expertise in medical research, gemaker determined the global pharmaceutical market’s spend (current and 5-year projection) on particular studies to understand disease and develop new drugs.